[ Visit Client Website ]

Before you can access ASH's online program, you must agree to the following:
  • Abstracts submitted to the ASH Annual Meeting are considered embargoed from the time of submission.
  • The media, companies and institutions issuing press releases, and others are required to abide by the embargo policies governing the Society’s annual meeting. Read ASH’s embargo policy for more information.

331.P1.49 Pathophysiology of Thrombosis: Poster I

Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 5, 2010: 6:00 PM-8:00 PM
Hall A3/A4 (Orange County Convention Center)
Prevalence of Venous Thromboembolism In Patients with Secondary Polycythemia

Omar Nadeem, M.D.1*, Jiang Gui, Ph.D2* and Deborah L. Ornstein, MD3

1Internal Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH
2Hematology/Oncology, Dartmouth-Hitchcock Medical Center, Lebanon, NH
3Pathology, Dartmouth-Hitchcock Medical Center, Lebanon, NH

Poster Board Number: II-1044
Implication of Tissue-Factor Bearing Microparticles In Thrombosis Associated with Breast Cancer

François Mullier1*, Damien Gheldof2*, Severine Robert2*, Nicolas Bailly3*, Philippe Devel2*, Chantal Doyen, MD4, Christian Chatelain5, Carine Michiels6*, Bernard Chatelain3 and Jean-Michel Dogné2*

1Hematology laboratory, UCL Mont-Godinne, Namur Research Institute for LIfe Sciences (NARILIS), Yvoir, Belgium
2Department of Pharmacy, University of Namur, Namur Research Institute for LIfe Sciences (NARILIS), Namur, Belgium
3Hematology Laboratory, UCL Mont-Godinne, Namur Research Institute for LIfe Sciences (NARILIS), Yvoir, Belgium
4Hematology, UCL Mont-Godinne, Namur Research Institute for LIfe Sciences (NARILIS), Yvoir, Belgium
5Hematology, UCL Mont-Godinne,Namur Research Institute for LIfe Sciences (NARILIS), Mont Godinne, Belgium
6Department of Biology, University of Namur,Namur Research Institute for LIfe Sciences (NARILIS),, Namur, Belgium

Poster Board Number: II-1045
Is Higher Soluble P-Selectin a Risk Factor for Chronic Venous Insufficiency?

Locke J Bryan, M.D.1*, Peter Callas, Ph.D.2*, Michael Criqui, M.D., M.P.H.3* and Mary Cushman, M.D., M.Sc.4

1Internal Medicine, University of Vermont, Fletcher Allen Health Care, Burlington, VT
2Biostatics Unit, University of Vermont College of Medicine, Burlington, VT
3Family and Preventive Medicine, University of California, San Diego, La Jolla, CA
4Hematology and Oncology, University of Vermont, Fletcher Allen Health Care, Burlington, VT

Poster Board Number: II-1046
Symptomatic and Incidental Thromboses Are Both Associated with Mortality In Pancreatic Cancer

Laurel A. Menapace1*, Derick R. Peterson, Ph.D.2*, Andrea Berry, M.S.2*, Tarek Sousou, M.D.3* and Alok A. Khorana, M.D.3

1University of Rochester School of Medicine & Dentistry, Rochester, NY
2Department of Biostatistics, University of Rochester, Rochester, NY
3Department of Medicine, University of Rochester, Rochester, NY

Poster Board Number: II-1047
Long-Term Survival of Patients with a History of Venous Thromboembolism

Sylvia Elisabeth Reitter, Dr.1*, Thomas Waldhoer, Dr.2*, Michaela Mayerhofer, Dr.1*, Ernst Eigenbauer, Dipl.-Ing.3*, Cihan Ay, Dr.1*, Paul Alexander Kyrle, MD4 and Ingrid Pabinger, MD5

1Department of Medicine I, Medical University of Vienna, Vienna, Austria
2Center for Public Health, Department of Epidemiology, Medical University of Vienna, Vienna, Austria
3Section of Medical Information Management und Imaging, Center for Medical Statistics, Infomatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria
4Medizinische Universitaet Wien, Vienna, Austria
5Dept. of Medicine I, Hematology & Hemostaseology, Vienna, Austria

Poster Board Number: II-1048
  Impact of Persistent Antiphospholipid Antibodies on Symptomatic Thromboembolism In Children: A Systematic Review & Meta-Analysis [Observational Studies]

Gili Kenet, MD1, Mariana Bonduel2*, Anthony K.C. Chan, MD3, Neil Goldenberg4*, Suzzane Holtzhauer5*, Alfonso Iorio6*, Janna M. Journeycake, MD7, Ralf Junker8*, Christoph Male, MD9*, Mary Patricia Massicotte, MD10*, Rolf M. Mesters, MD11, Paul Monagle, MBBS, MD, MSc12, Heleen Van Ommen13*, Leslie Raffini, MD14, Paolo Simioni15*, Guy Young, MD16 and Ulrike Nowak-Gottl, MD17

1Thrombosis Unit, National Hemophilia Center, Tel Hashomer, Israel
2Hematology, Hospital de pediatria, Buenos Aires, Argentina
3Pediatrics, McMaster University, Hamilton, ON, Canada
4Pediatric Hematology, Mountain States Regional Hemophilia and Thrombosis Center, University of Colorado, Aurora, CO
5Charite, Berlin, Germany
6University of Perugia, Perugia, Italy
7University of Texas Southwestern Medical Center at Dallas, Dallas, TX
8Ins of Clinical Chemistry and laboratory medicine, Muenster, Germany
9Medical University Vienna, Vienna, Austria
10Pediatric Thrombosis Program, UAB/Stollery Children's Hosp., Edmonton, AB, Canada
11Medicine A - Hematology, Oncology and Pneumology, University of Muenster, Munster, Germany
12Dept. of Paediatrics, The University of Melbourne, Parkville, Australia
13Emma Children's hospital, Amsterdam, Netherlands
14Hematology, Children's Hospital of Philadelphia, Philadelphia, PA
15University of Padua, Padua, Italy
16Children's Hospital Los Angles, Los Angeles, CA
17Dept. of Pediatric Hem./Onc., University Children's Hospital, Munster, Germany

Poster Board Number: II-1049
Systematic Review of the Surgical Treatment of Moderate to Severe Post-Thrombotic Syndrome

Rachel T Bond1*, Jacqueline M. Cohen2* and Susan R. Kahn, MD, MSc3

1McGill University, Montreal, QC, Canada
2McGill University, Montreal, Canada
3Centre for Clinical Epidemiology and Community Studies, Jewish General Hospital, Montreal, Canada

Poster Board Number: II-1050
Frequency and clinical outcomes of platelet membrane glycoprotein polymorphisms in antiphospholipid syndrome 

Ipek Yonal1*, Fehmi Hindilerden1*, Veysel Sabri Hancer2*, Bahar Artim Esen3*, Meliha Nalcaci1* and Reyhan Diz Kucukkaya2*

1Hematology, Istanbul University Istanbul Medical Faculty, Istanbul, Turkey
2Hematology, Istanbul Bilim University, Istanbul
3Rheumatology, Istanbul University Istanbul Medical Faculty, Istanbul

Poster Board Number: II-1051
Mean Platelet Volume (MPV) Analysis In Patients with Coronary Arterial Disease

Bianca Rodrigues1*, Hudson Hubner França1*, Jose R Maiello2*, Soraia Romanini3*, Fernanda Pasuld1*, Ednilson Nunes1* and Marcelo Cliquet1

1MEDICINE, PUC/SP, Sorocaba, Brazil
2Medicine, PUC/SP, Sorocaba, Brazil
3PUC/SP, Sorocaba, Brazil

Poster Board Number: II-1052
A Predictive Risk Score for Cancer-Associated Thrombosis: Role of Screening In A Prospective Study

Alok A. Khorana, M.D.1, Kimberly Herman2*, Deborah Rubens1* and Charles W. Francis, MD3

1Department of Medicine, James P. Wilmot Cancer Center, Rochester, NY
2James P. Wilmot Cancer Center, University of Rochester, Rochester
3Univ. of Rochester Med. Ctr., Rochester, NY

Poster Board Number: II-1053
Measurements of Prothrombin Fragment 1.2 In Urine and Blood to Assess Hypercoagulability In Preeclampsia

Anita Sylvest Andersen, MD1*, Anna-Marie Münster, MD, PhD2*, Thomas Bergholt, MD, PhD1*, Isabelle Deltour3*, Merete Bak Bertelsen4*, Jawed Fareed, PhD5 and Michael Rud Lassen, MD6*

1Department of Gynecology and Obstetrics, Copenhagen University Hospital, Hillerød, Denmark
2Department of Clinical Bio-chemistry, Aalborg Hospital, Aalborg, Denmark
3Danish Cancer Society, Institute of Cancer Epidemiology, Copenhagen, Denmark
4Orthopedics, Spine Clinic, Clinical Trial Unit, Horsholm Hospital, University of Copenhagen, Horsholm, Denmark
5Pathology and Pharmacology, Loyola University Chicago, Maywood, IL
6Spine Center Copenhagen, Copenhagen University Hospital Glostrup, Glostrup, Denmark

Poster Board Number: II-1054
Pharmacological Study of Antimyeloma Agents on Hemostasis

François Mullier1*, Severine Robert2*, Philippe Devel2*, Lutfiye Alpan2*, Nicolas Lufin2*, Bernard Chatelain3 and Jean-Michel Dogné2*

1Hematology laboratory, UCL Mont-Godinne, Namur Research Institute for LIfe Sciences (NARILIS), Yvoir, Belgium
2Department of Pharmacy, University of Namur, Namur Research Institute for LIfe Sciences (NARILIS), Namur, Belgium
3Hematology Laboratory, UCL Mont-Godinne, Namur Research Institute for LIfe Sciences (NARILIS), Yvoir, Belgium

Poster Board Number: II-1055
Racial Differences In Pediatric Venous Thromboembolism

Madhvi Rajpurkar, MD1, Cynthia Sabo, MSN, RN, CPNP1*, Ayesha N Zia, MD2, Michael U Callaghan, MD3, Bulent Ozgonenel, MD3, Meera Chitlur, MD4* and Jeanne M. Lusher, MD5

1Carman and Ann Adams Dept. of Pediatrics , Division of Hematology Oncology, Children's Hosp. of MI, Detroit, MI
2Carman and Ann Adams Department of Pediatrics , Division of Hematology Oncology, Children's Hosp. of MI, Detroit, MI
3Carman and Ann Adams Department of Pediatrics , Division of Hematology Oncology, Children's Hospital of Michigan, Detroit, MI
4Carman and Ann Adams Department of Pediatrics, Division of Hematology Oncology, Children's Hospital of Michigan, Detroit, MI
5Carman and Ann Adams Department of Pediatrics , Division of Hematology Oncology, Children's Hospital of MI, Detroit, MI

Poster Board Number: II-1056
The Metabolic SYNDROME and the RISK of Venous Thrombosis: RESULTS of AN Individual LEVEL Patient Meta-ANALYSIS

Francesco Dentali, MD1, Cihan Ay, MD2*, Moon Jang3*, Matteo di Minno4*, Ingrid Pabinger, MD5, Doyeun Oh6*, Giovanni di Minno4*, Alessandro Squizzato7*, anna Maria Grandi7* and Walter Ageno, MD7*

1Clinical Medicine, University of Insubria, Varese, Italy, Gornate Olona, Italy
2Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
3Department of Internal Medicine, School of Medicine, CHA University, Seungnam, South Korea
4Federico II University, Napoli, Italy
5Dept. of Medicine I, Hematology & Hemostaseology, Vienna, Austria
6Pochon CHA University, Sungnam, South Korea
7Clinical Medicine, University of Insubria, Varese, Italy

Poster Board Number: II-1057
Statin Therapy and Levels of Thrombosis Risk Factors In a Healthy Population:  the Multi-Ethnic Study of Atherosclerosis

Nathan B. Adams, MD, MS1*, Pamela Lutsey, PHD2*, Aaron Folsom, MD2*, David Herrington, MD3*, Christopher T Sibley, MD4*, Neil Zakai, MD, MSc5, Steven Ades, MD1*, Gregory Burke, MD, MSc6* and Mary Cushman, MD, MSc5

1Hematology/Oncology, University of Vermont, Burlington, VT
2University of Minnesota, Minneapolis, MN
3Internal Medicine/Cardiology, Wake Forest University School of Medicine, Winston-Salem, NC
4National Institutes of Health, Clinical Centers, Bethesda, MD
5Medicine and Pathology, University of Vermont, Burlington, VT
6Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC

Poster Board Number: II-1058
The Utility of Thromboelastography (TEG) In the Management of Patients with Isolated Antiphospholipid Antibodies (aPL) or Primary Antiphospholipid Syndrome (PAPS)

Karen A Breen, MB* and Beverley J Hunt, MD*

Thrombosis and Vascular Biology, Guys and St Thomas' NHS Trust, London, United Kingdom

Poster Board Number: II-1059
Outcomes of Pulmonary Embolism In Surgical Patients: A Retrospective Cohort Study

Gauruv Bose1*, Esteban Gandara1*, Marc Carrier, MD, MSc2, Petra MG Erkens3*, Marc Rodger2 and Philip Wells, MD, FRCPC, MSc4

1Department of Medicine, Ottawa Hospital, Ottawa, ON, Canada
2University of Ottawa, Ottawa, ON, Canada
3Maastricht University, Maastricht, Netherlands
4Ottawa Hospital General Site, Ottawa, ON, Canada

Poster Board Number: II-1060
Decreased Activity of ADAMTS13 In Patients with Deep Vein Thrombosis Associated with Inflammatory Markers

Bruna m Mazetto1*, Fernanda Loureiro de Andrade Orsi, MD, PhD2, Aline Barnabé1*, Marinez Farana Matos, PhD3*, Erich V de Paula, MD, PhD4*, Vânia Maris Morelli, MD, PhD5* and Joyce M Annichino-Bizzacchi, MD, PhD6*

1Hematology and Hemoterapy Center, State Universty of Campinas, Campinas, Brazil
2Hematology and Hemoterapy Center, University of Campinas, UNICAMP, Campinas, Brazil
3Universidade Federal de São Paulo, Hematology and Blood Transfusion Division, São Paulo, Brazil
4Hematology and Hemotherapy Center , University of Campinas, UNICAMP, Campinas, Brazil
5Hematology and Blood Transfusion Division, Universidade Federal de São Paulo, São Paulo, Brazil
6Hematology and Hemotherapy Center, University of Campinas, UNICAMP, INCT do Sangue, Campinas, Brazil

Poster Board Number: II-1061
Systematic Review of Antiphospholipid Syndrome and Left Ventricular Thrombus

David S Kotlyar, MD1*, Iosif Kelesidis, MD2*, Sofya Pintova, MD1*, Aarti Bhardwaj, MD1*, Amala Chirumamilla, MD2*, Per Sommer, MD2*, Mark A Menegus, MD2* and Robert J Ostfeld, MD2*

1Department of Medicine, Albert Einstein College of Medicine/Montefiore Med Ctr., Bronx, NY
2Division of Cardiology, Dept. of Medicine, Albert Einstein College of Medicine/Montefiore Med Ctr., Bronx, NY

Poster Board Number: II-1062
Thrombin Generation During Abdominal Surgical Procedures: Effect of Prophylactic Anticoagulation Therapy

Annemarie E. Fogerty, MD1, Amy Colwell, MD2*, Jay William Austen Jr., MD2* and David J. Kuter, MD, DPhil3

1Hematology, Massachusetts General Hospital, Boston, MA
2Plastic Surgery, Massachusetts General Hospital, Boston, MA
3Massachusetts General Hospital, Harvard Medical School, Boston, MA

Poster Board Number: II-1063
Prevalence of Thrombophilia In Patients with Sickle Cell Disease and Osteonecrosis

Murtadha K. Al-Khabori, MD, FRCPC1, Anil Pathare, MD, FCPS, FIMSA, Ph.D2*, Khalil Al Farsi, MD, FRCPC2, Mohammed Al Huneini, MD, FRCPC2* and Salam Alkindi, BA, MB, BCh, BAO, DME, MSc, FRCP3

1Hematology, Sultan Qaboos University Hospital, Muscat, Oman
2College of Medicine, Department of Haematology, Sultan Qaboos University Hospital, Muscat, Oman
3College of Medicine, Department of Haematology, Sultan Qaboos University, Muscat, Oman

Poster Board Number: II-1064
Detection of Lupus Anticoagulant In Women with Obstetric complications

Andrea Laura Avigliano, Bioq1*, Juan Carlos Galli, Bioq2* and Beatriz Grand, MD1*

1Hematologia y Hemostasia, Stamboulian Laboratorio, Buenos Aires, Argentina
2Stamboulian Laboratorio, Buenos Aires, Argentina

Poster Board Number: II-1065
Safety and Clinical Utility of Four Clinical Decision Rules In the Diagnostic Management of Acute Pulmonary Embolism – the Prometheus Diagnosis Study

Inge CM Mos, MD1*, Renée A Douma, MD2*, Petra MG Erkens, MSc3*, Tessa AC Nizet, MD4*, Marc F Durian, MD5*, Anja A van Houten, MD6*, Marcel M Hovens, MD7*, Herman MA Hofstee, MD8*, Frederikus A Klok, MD1*, Hugo Ten Cate, MD9, Erik F Ullmann, MD4*, Harry R Büller, MD2*, Pieter W Kamphuisen, MD2* and Menno V Huisman, MD1*

1Department of General Internal Medicine - Endocrinology, Leiden University Medical Center, Leiden, Netherlands
2Department of Vascular Medicine, Academic Medical Center, Amsterdam, Netherlands
3Lab Clinical Thrombosis and Haemostasis, Maastricht University Medical Center, Maastricht, Netherlands
4Department of Pulmonary Medicine, Rijnstate Hospital, Arnhem, Netherlands
5Department of Hematology, Erasmus University Medical Center, Rotterdam, Netherlands
6Department of Internal Medicine, Maasstad Hospital, Rotterdam, Netherlands
7Department of Internal Medicine, Rijnstate Hospital, Arnhem, Netherlands
8Department of Internal Medicine, VU University Medical Center, Amsterdam, Netherlands
9Department of Internal Medicine, Maastricht University Medical Center, Maastricht, Netherlands

Poster Board Number: II-1066
Novel Thrombogenic Biomarkers In Patients with Relapsed/Refractory Multiple Myeloma (MM) Treated with Lenalidomide (LEN) and Dexamethasone (Dex) Therapy

Kate Burbury, MBBS, FRACP, FRCPA, DPhil1*, Peter C Gambell2*, Amanda Choo3*, Jennifer Curnow, MBBS, PhD, FRACP, FRCPA4*, Kevin Lynch, MBBS5*, Simon J. Harrison, MBBS MRCP (uk) MRCPath (uk) PhD6, Hang Quach7*, David Ritchie, MBBS, FRACP, FRCPA7*, Miles Prince, MD, FRACP, FRCPA8 and David Alan A Westerman, MBBS, FRACP, FRCPA2

1Department of Hematology and Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia
2Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia
3Hematology, Peter MacCallum Cancer Centre, Melbourne, Australia
4Concord Haematology, Concord Hospital, Sydney
5Celgene Pty Ltd, Melbourne, Australia
6Peter MacCallum Cancer Centre, Melbourne, Australia
7Dept. of Hem. & Med. Onc., Peter MacCallum Cancer Inst., Melbourne, VIC, Australia
8Divison of Haematology, Peter MacCallum Cancer Centre, East Melbourne, Australia

Poster Board Number: II-1067
Analysis of Ordering Practice of Thrombophilia Testing at a Single Large Teaching Hospital

Judy Peih-Ying Tsai, MD1*, Evelyn O. Taiwo, MD1, Natalie Cervantes2*, Guadalupe Jasso2*, Eugene P. Frenkel, MD1*, Ravindra Sarode, MD3 and Yu-Min P Shen, MD4

1Internal Medicine, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX
2Office of Equal Opportunity and Minority Affairs, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX
3Pathology, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX
4Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, TX

Poster Board Number: II-1068

*signifies non-member of ASH